Whitehawk Therapeutics (WHWK) Equity Ratio (2018 - 2025)
Historic Equity Ratio for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to 0.94.
- Whitehawk Therapeutics' Equity Ratio rose 1709.99% to 0.94 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.94, marking a year-over-year increase of 1709.99%. This contributed to the annual value of 0.75 for FY2024, which is 605.52% down from last year.
- According to the latest figures from Q3 2025, Whitehawk Therapeutics' Equity Ratio is 0.94, which was up 1709.99% from 0.95 recorded in Q2 2025.
- Over the past 5 years, Whitehawk Therapeutics' Equity Ratio peaked at 0.95 during Q2 2025, and registered a low of 0.75 during Q4 2024.
- For the 5-year period, Whitehawk Therapeutics' Equity Ratio averaged around 0.87, with its median value being 0.86 (2021).
- Its Equity Ratio has fluctuated over the past 5 years, first crashed by 1077.81% in 2024, then surged by 2272.88% in 2025.
- Whitehawk Therapeutics' Equity Ratio (Quarter) stood at 0.86 in 2021, then decreased by 0.48% to 0.86 in 2022, then decreased by 7.59% to 0.79 in 2023, then dropped by 6.06% to 0.75 in 2024, then rose by 26.1% to 0.94 in 2025.
- Its Equity Ratio stands at 0.94 for Q3 2025, versus 0.95 for Q2 2025 and 0.95 for Q1 2025.